Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURI.L Share News (PURI)

  • There is currently no data for PURI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PuriCore Revenue Drops In Quarter As Change To Product Mix Continues

Fri, 31st Oct 2014 10:29

LONDON (Alliance News) - PuriCore PLC Friday reported a decline in third quarter revenue, amid the continued rebalancing of its supermarket retail product mix, as consumable product sales increase and capital equipment sales decline.

In a statement, PuriCore reported USD4.7 million of revenue from continuing operations in the third quarter, compared with USD9.5 million in the corresponding period last year. The company completed the disposal of the UK Endoscopy business on June 30, meaning the results of operations for that business are reported as discontinued operations.

Over the nine months to September 30, revenue from continuing operations decreased to USD13.2 million from USD21.9 million in the corresponding period last year.

PuriCore said that, as expected, 2014 revenues and earnings will be lower than in the prior year, as its supermarket retail business model transitions and investments are made across the group to support longer-term growth.

"The company will remain vigilant in controlling costs and preserving cash while prudently investing for the future. The board has advanced the strategic and operational review of the business and plans to announce further details later this year," according to the company's statement.

Chief Executive Michael Ashton said: "The lower reported revenue for the period is consistent with the announced change in the supermarket retail business, from a capital sales driven business model to one that will deliver more consistent recurring revenues. We are confident that this shift is the right strategy for the longer-term success of the business."

"Through the strategic review, we have identified new growth opportunities across the Group in which we will invest while implementing focused cost reduction plans elsewhere," Ashton said. "These opportunities entail new products and applications as well as geographic expansion and centre on leveraging PuriCore's patented technology. As the strategy continues to evolve, we will share further updates with the market later this year."

PuriCore shares were down 12% at 30.00 pence on Friday.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
10 Oct 2016 14:22

PuriCore completes disposal of supermarket retail business

(ShareCast News) - Emerging specialty biopharmaceutical company PuriCore announced on Monday that the disposal of its supermarket retail business, as first indicated on 20 September, had completed. The AIM-traded firm said gross proceeds of the sale were $13.5m, subject to a final adjustment for net

Read more
20 Sep 2016 14:51

PuriCore flogs off supermarket business, posts wider loss

(ShareCast News) - Specialty biopharmaceutical company PuriCore announced its interim financial results for the six months to 30 June on Tuesday - a period in which the group confirmed its strategic focus to develop novel, prescription treatments for inflammatory diseases including dermatology, opht

Read more
17 Aug 2016 10:49

PuriCore secures two patents for immunomodulatory technology

(ShareCast News) - AIM-listed biopharma hopeful Puricore has been granted two US patents covering the technique for producing its 'immunomodulatory' therapy for inflammatory skin disorders. Puricore, which has developed proprietary immunomodulatory formulations that reduce the immune reaction and ca

Read more
9 Jun 2016 15:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
9 Jun 2016 07:53

PuriCore To Submit New Drug Application For PR022 To FDA In 2017

Read more
27 May 2016 07:22

PuriCore To Stop Selling ProduceFresh Until Registered As Pesticide

Read more
14 Apr 2016 08:07

PuriCore Appoints Christian Peters As Chief Medical Officer

Read more
29 Mar 2016 14:52

DIRECTOR DEALINGS: PuriCore CEO Buys 100,000 Shares

Read more
24 Mar 2016 10:25

PuriCore Considers Spin-Off Of Supermaket Retail Unit As Revenue Rises

Read more
1 Mar 2016 11:15

PuriCore Appoints Balkrishan Gill To Board As Non-Executive

Read more
8 Feb 2016 08:24

PuriCore Mulls Supermarket Retail Unit Sale As It Switches Focus

Read more
14 Oct 2015 16:17

DIRECTOR DEALINGS: PuriCore Non-Executive Buys Shares

Read more
28 Sep 2015 08:58

DIRECTOR DEALINGS: PuriCore Chairman Doubles Holding

Read more
23 Sep 2015 09:33

PuriCore Loss Widens On Gross Margin Hit And Investments, But Sales Up

Read more
19 May 2015 07:54

PuriCore Appoints Alex Martin As New Chief Executive Officer

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.